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Abstract
Background: Very small embryonic-like stem cells (VSELs) are a rare population within the ovarian epithelial surface.
They contribute to postnatal oogenesis as they have the ability to generate immature oocytes and resist the
chemotherapy. These cells express markers of pluripotent embryonic and primordial germ cells.
Objective: We aimed to explore the capability of VSELs in restoring the postnatal oogenesis of chemo-ablated rat
ovaries treated with bone marrow-derived mesenchymal stem cells (BM-MSCs) combined with pregnant mare
serum gonadotropin (PMSG).
Methods: Female albino rats were randomly assigned across five groups: I (control), II (chemo-ablation), III (chemo-
ablation + PMSG), IV (chemo-ablation + MSCs), and V (chemo-ablation + PMSG + MSCs). Postnatal oogenesis was
assessed through measurement of OCT4, OCT4A, Scp3, Mvh, Nobox, Dazl4, Nanog, Sca-1, FSHr, STRA8, Bax, miR143,
and miR376a transcript levels using qRT-PCR. Expression of selected key proteins were established as further
confirmation of transcript expression changes. Histopathological examination and ovarian hormonal assessment
were determined.
Results: Group V displayed significant upregulation of all measured genes when compared with group II, III or IV.
Protein expression confirmed the changes in transcript levels as group V displayed the highest average density in
all targeted proteins. These results were confirmed histologically by the presence of cuboidal germinal epithelium,
numerous primordial, unilaminar, and mature Graafian follicles in group V.
Conclusion: VSELs can restore the postnatal oogenesis in chemo-ablated ovaries treated by BM-MSCs combined
with PMSG.
Keywords: Ovarian chemo-ablation, MSCs, Postnatal oogenesis, VSELs, Gonadotropins
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: rabab.bio@yahoo.com
15Department of Medical Biochemistry and Molecular Biology, Faculty of
Medicine, Benha University, Benha, Qalyubia 13512, Egypt
Full list of author information is available at the end of the article
Ebrahim et al. Stem Cell Research & Therapy          (2021) 12:517 
https://doi.org/10.1186/s13287-021-02415-5
Introduction
Mammalian ovaries are responsible for competent ma-
ture oocyte formation. They are also responsible for the
secretion of a variety of hormones, growth factors and
cytokines that contribute to key signaling pathways of
oogenesis and folliculogenesis. Premature ovarian failure
(POF) therefore results in the loss of reproductive ability
and early menopause [1]. POF is manifested by amenor-
rhea, sex steroid hormone deficiency with elevated
(menopausal) levels of serum gonadotropins, before the
age of 40 years [2]. It is not a rare condition with an oc-
currence of approximately 6% in women of less than 40
years of age [3]. Further, reflecting advanced treatment
options, more than 80% of young cancer patients survive
with infertility as a side effect [4]. Currently, there is no
standard approach for preventing radiation/chemother-
apy-induced ovarian failure. Cryopreservation is the only
established and standard method for fertility preserva-
tion in young women with cancer [5]. Thus, it is essen-
tial to identify better strategies to prevent ovary
dysfunction during chemotherapy and restore ovary
function after chemotherapy.
Postnatal oogenesis has emerged as a key theme within
female reproductive science. This has challenged estab-
lished concepts within reproductive science including
that all female mammals possess a constant pool of oo-
cytes, which is not subjected to renewal during postnatal
life [6]. However, experimental research in adult female
mice verified that the imbalance between non-atretic fol-
licle number and the rate of atresia failed to clarify the
fixed number of germ cell theory [7]. This was accom-
panied by the display of mitotically active germ cells ex-
pressing meiotic markers within the adult ovary of mice.
These, and additional, observations reveal the occur-
rence of potential postnatal oogenesis through the exist-
ence of germline stem cells in mice and higher animal
species including human [8, 9].
The population of putative pluripotent stem cells
(PSCs) within the ovarian epithelial surface of adults
have been hypothesized to drive postnatal oogenesis [10,
11]. Neo-oogenesis requires germline stem cells (GSCs)
in the ovarian surface epithelium (OSE) with the ability
to differentiate into oocyte, granulosa phenotype,
fibroblast-like cells, and in vitro, with the proper stimu-
lation, into mesenchymal cell lineages. Endpoint indica-
tions ranging from oocyte quantification, genetic lineage
tracing, and transplantation support a paradigm shift in
reproductive biology that includes active renewal of
oocyte-containing follicles throughout postnatal life [12].
Previous reports have indicated that a population of
stem cells in the adult human ovaries may have the
potential to develop into an oocyte-like, embryoid body-
like structure via their differentiation into the three em-
bryonic layers in vitro [13, 14]. Taken together, these
observations offer a potential role for these PSCs in aid-
ing infertile couples conceive. Nevertheless, there re-
mains substantial concern around postnatal oogenesis
and its challenge to the fixed germ cell pool theory [15].
Quiescent and active stem cell populations are evi-
denced across multiple organs including skin, gut, brain
[16], and gonads. The gonadal stem cells consist of two
distinctive populations, specifically, the relatively “quies-
cent” very small embryonic-like stem cells (VSELs), and
the committed “active” progenitor stem cell that in-
cludes ovary germ stem cells (OGSCs) in the ovary [17]
and spermatogonial stem cells in testis [18]. These two
populations are distinguishable due to their size, expres-
sion of octamer-binding transforming factor 4 (OCT-4)
isoforms, and their capacity to proliferate [19]. Ovarian
stem cells have been identified in the ovaries of peri-
menopausal women (including a 60-year-old woman)
with no naturally present follicles or oocytes [9] and
aged mice [20]. However, ovarian microenvironment be-
comes unsuitable for ovarian stem cells to proliferate
and differentiate. So, if we try to improve the micro-
environment to become suitable for proliferation and
differentiation of ovarian stem cells, the postnatal oogen-
esis will be improved [17].
Follicle-stimulating hormone (FSH) is a pleiotropic
hormone manufactured by the pituitary that utilizes its
action on mammalian ovaries through prompting prolif-
eration, differentiation, and finally steroidogenesis within
the granulosa cells of the developing pre-ovulatory folli-
cles. However, the initial development of primordial fol-
licles (PF) is believed to be FSH independent [21].
Mesenchymal stem cells (MSCs) are a well-
characterized non-hematopoietic adult stem cell derived
from a wide range of tissues including bone marrow.
Though conventionally isolated from bone marrow,
MSCs have also been found in various additional adult
tissues including umbilical cord, adipose tissue, liver,
placenta and dental pulp. MSCs have substantial prom-
ise in therapeutic regenerative medicine application with
strong potential in non-autologous transplantation ap-
proaches, due to their lack of MHC class II expression
[22]. In addition, MSCs have anti-inflammatory, antifi-
brotic, antiapoptotic, and immunomodulatory effects
that are paracrine in nature and have been verified in
various pre-clinical studies and clinical indications.
These distinctive features have created suitability across
numerous medical indications where therapeutic inter-
vention, tissue engineering, and cell therapy sit as cred-
ible options [23]. Included amongst this list is their
potential application in reproductive health disorders in-
cluding premature ovarian failure as MSCs are described
as partially ameliorating hormonal function, folliculogen-
esis, and architecture of chemotherapy damaged ovaries
of albino rats [24]. Further assessment is required to
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explore the effectiveness of these cells in infertility treat-
ment and reproductive science [25, 26].
Therefore, in the present study, we assessed the cap-
ability of VSELs to restore the postnatal oogenesis in
chemo-ablated ovaries treated with BM-MSCs combined
with gonadotropin. We observed that the gonadotropin
alone positively affected VSEL proliferation but that suc-
cessful differentiation to primordial cells required MSC-




Nulliparous and sexually mature female albino rats
within the diestrus (DE) phase (180–200 g), aged 6
weeks, were purchased from the Experimental Animal
Unit, Faculty of Veterinary Medicine, Benha University,
Egypt. The different stages of the estrus cycle were
examined via daily examination of vaginal smears where,
concisely, the vaginal swabs were prepared by means of
sterile PBS-dipped cotton swabs, fixed in 100% metha-
nol, stained with Giemsa, and examined underneath the
microscope (Nikon, Tokyo, Japan). Rats were bred and
kept up in an air-conditioned animal house under specific
pathogen-free conditions. All animals were accommo-
dated in clean cages and given a standard diet and clean
water ad libitum. Rats were exposed to the normal light/
dark cycle (12-h light-dark cycle starting at 8:00 AM),
room temperature (23 ± 3 °C) and free access to chow and
water were allowed. This study was carried out in a strict
accordance with the approvals in the Guide for the Care
and Use of Laboratory Animals of the National Institutes
of Health (NIH publication No. 85–23, revised 2011). All
protocols were permitted by the institutional review board
for animal experiments of the Faculty of Medicine, Benha
University, Egypt (BUFM 3 January 2018).
Preparation and tracking of BM-derived MSC
Rats BM-MSCs were prepared in the Stem Cell Unit,
Central Lab, Faculty of Medicine, Benha University. BM-
MSCs cells were flushed from the tibia and fibula of rat
bones by phosphate-buffered saline (PBS) having 2ml
EDTA. The diluted sample was cautiously layered over
Ficoll-Paque (Gibco-Invitrogen, Grand Island, NY), cen-
trifuged for 35 min at 400 rpm and the higher layer aspi-
rated leaving the mononuclear cell (MNC) layer at the
interphase. This MNC layer was aspirated, washed twice
in PBS having 2 ml EDTA and centrifuged for 10 min at
200 rpm at 10 °C. The pellet of cells was re-suspended in
PBS/EDTA before being seeded into T25 flasks in min-
imal essential medium (MEM) supplemented with 15%
fetal bovine serum (FBS) at 37 °C and 5% CO2. The ad-
herent BM-MSCs were cultured with MEM supple-
mented with 30% FBS, 0.5%, streptomycin, penicillin and
at 37 °C in 5% CO2 in air [27]. All cultures were tested
via an inverted microscope; Leica DM IL LED with cam-
era Leica DFC295 (Leica Microsystems CMS GmbH,
Ernst-Leitz- Straße 17-37, Wetzlar, D-35578, Germany)
[28].
Immunophenotyping characterization of differentiated
stem cells
BM-MSCs were primarily characterized by their adhe-
siveness, fusiform morphology, and through the recog-
nition of the well known surface markers of rat BM-
MSCs via flow cytometry. Subsequent the isolation,
BM-MSC were passaged, viable cell counts recognized,
and aliquoted individually at 1 × 106 cells/mL per tube.
BM-MSC were then incubated with 10 μL of directly
conjugated monoclonal antibodies; CD34 PE (rabbit
monoclonal; EP373Y, ab223930), CD90 PE (mouse
monoclonal Antibody (HIS51), eBioscience, # 14-0900-
81), and CD 105 PE (rabbit polyclonal antibody, CENT
ER E395; SAB1306487 Sigma-Aldrich) at 4 °C in the
dark for 20 min; matched isotype controls were in-
cluded for control purposes. Subsequent the incuba-
tion, 2 mL of PBS containing 2% FCS solution was
added to each tube followed by centrifugation for 5 min
at 2500 rpm, discarding of the supernatant, and resus-
pending in 500 μL PBS containing 2% FCS. Cell analysis
was executed using CYTOMICS FC 500 Flow Cyt-
ometer (Beckman Coulter, Brea, CA, USA) and CXP
software version 2.2 [29].
In vitro adipogenic, chondrogenic, and osteogenic
differentiation of MSCs
BM-MSCs were examined for their capability to undergo
trilineage differentiation into adipocytes, osteoblasts, and
chondrocytes. Passage 4 MSCs at a density of 5 × 103
cells/cm2 were seeded into precoated coverglass situated
within six-well plates and encouraged for 3 weeks with
either adipogenic (HUXMA-90031; Cyagen Biosciences
Inc., Guangzhou, China), osteogenic (#HUXMA-90021;
Cyagen Biosciences Inc.), or chondrogenic (#HUXMA-
90041; Cyagen Biosciences Inc.) differentiation media,
respectively. The cells were then fixed in 10% formalin
and stained with either Oil Red O, Alizarin red, or
Alcian blue according to standard procedures [30].
Labeling stem cells with green fluorescent protein (GFP)
BM-MSCs were transfected with non-integrating
plasmids containing GFP (addgene, PET His6 GFP TEV
LIC cloning vector (1GFP) (Plasmid #29663). One day
earlier to the transfection, 5 × 105 cultured cells were
plated in 1 ml complete growth medium and BM-MSCs
transfected with a single plasmid using the Nucleofector
kit (Lonza, Verviers, Belgium) according to the manufac-
turer’s instructions [31]. BM-MSCs labeled with GFP
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were detected via a fluorescence microscope (Leica
Microsystems CMS GmbH, Ernst-Leitz-Straße, Wetzlar,
D-35578, Germany).
Induction of ovarian ablation:
Rats were administered with 10 mg/kg busulfan daily for
4 days and 100 mg/kg cyclophosphamide on the first 2
days resulting in complete germ cell depletion. Busulfan
(Sigma-Aldrich, Missouri) was dissolved in dimethyl
sulfoxide (Sigma-Aldrich), diluted with an equal volume
of water, and injected via the intraperitoneal route.
Cyclophosphamide (Baxter, India) was dissolved in ster-
ile injection-grade water and also injected via intraperi-
toneal route after 1 to 2 h of busulfan injection [32].
Experimental design and treatment protocol
Fifty-six rats were divided randomly into five groups as
follows:
 Group I (control group): Twenty-eight rats were
subdivided equally into 4 subgroups (7 animals per
group):
– Subgroup a: Rats with no intervention.
– Subgroup b: Rats were injected with dimethyl
sulfoxide (Sigma-Aldrich), diluted with an equal
volume of water, and injected via the
intraperitoneal route.
– Subgroup c: Rats were injected with sterile
injection-grade water via the intraperitoneal
route.
– Subgroup d: Rats were injected intraperitoneally
with sterile phosphate-buffered saline solution.
 Group II (chemo-ablation group; OA group): seven
rats underwent induction of ovarian ablation by
injecting busulfan 10 mg/kg daily for 4 days and 100
mg/kg cyclophosphamide in the first 2 days.
 Group III (OA + PMSG group): Seven rats were
injected subcutaneously 5 IU PMSG (National
Hormone & Peptide Program, Harbor-UCLA Med-
ical Center, California) 1 month after treatment with
busulfan and cyclophosphamide.
 Group IV (OA + BM-MSCs cell group): Seven rats
underwent ovarian chemo-ablation, then after 1
month, the rats received a therapeutic delivery of
MSC as a single intraperitoneal injection (1 × 106
MCSs were suspended in 0.5 mL of phosphate-
buffered saline).
 Group V (OA + PMSG+ BM-MSCs group): Seven
rats underwent ovarian chemo-ablation, and then
stem cells were injected by intraperitoneal route, as
above, combined with a single subcutaneous injec-
tion of 5 IU (pregnant mare serum gonadotropin
PMSG), after 1 month of chemo-ablation.
Sampling
Four weeks after gonadotropin administration and stem
cell injection, all rats were anesthetized by sodium thio-
pental anesthesia (40 mg/kg; I.P.) after 12 h of fasting.
The rats were fixed on an operating table and blood
samples obtained from retro-orbital venous plexus using
a fine-walled Pasteur pipette. This was followed by vas-
cular perfusion fixation by using 10% buffered formol sa-
line through the left ventricle. Following fixation, the
ovaries of rats of all groups were dissected for both
histopathological examination [hematoxylin and eosin
(H&E) and immunohistochemically staining for prolifer-
ating cell nuclear antigen (PCNA) and FSHr] in addition
to molecular analysis by real-time PCR and Western
blot.
Determination of serum FSH and estradiol E
concentrations
Orbital blood was obtained under anesthetized condi-
tions with chloral hydrate. The serum of rats was iso-
lated via centrifugation at 4 °C and stored at − 80 °C
until assay. The serum levels of FSH and estradiol E
were assessed using ELISA kits (Uscn Life Science Inc.,
Houston, TX, USA) and were read on ELISA Reader
(Thermo Fisher, Varioskan Flash, USA) following the
manufacturers’ guidelines. Measurements were done in
technical triplicate and the levels of FSH and estradiol E
presented as nanograms per milliliter.
Gene expression profile
Total RNA was extracted from the ovaries of all experi-
mental groups using TRIzol (Invitrogen) according to the
manufacturer’s instructions. The concentration and purity
of extracted RNA were assessed by the Nano-Drop 2000C
spectrophotometer (Thermo Scientific, USA). At absorb-
ance ratio A260/A280, RNA purity for all samples was >
1.9. The integrity of RNA was confirmed on 2% agarose
gel using a gel electrophoresis image (Gel Doc. Bio-Rad)
according to [33]. Complementary DNA (cDNA) was syn-
thesized for the target genes using SensiFast cDNA syn-
thesis kits (Sigma Bioline, UK) according to the
manufacturer’s instruction. NCode VILO miRNA cDNA
Synthesis Kit (Invitrogen) was used for cDNA synthesis
from miRNAs following the manufacturer’s recommenda-
tions using a T100 Thermal Cycler (Bio-Rad, USA).
Quantitative PCR was done using Maxima SYBR
Green/ROX qPCR master mix (2x) (Thermo Scientific,
USA) according to [34]. Primer pairs for selected target
and reference genes (SCP3, synaptonemal complex pro-
tein 3; Mvh, mouse VASA homolog; Nobox, NOBOX
oogenesis homeobox; DAZL, deleted In azoospermia
like; Oct-4, octamer-binding transcription factor 4;
Nanog, Nanog Homeobox; Sca-1, stem cell antigen-1;
FSHr, follicle stimulating hormone receptor; Oct-4A,
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octamer-binding transcription factor 4 isoform A; Stra8,
stimulated by retinoic acid 8; BAX; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase) were pur-
chased from Genwez (New Jersey, USA) (Table 1). Each
PCR reaction consisted of 500 ng per reaction of cDNA
(except for NTC and cDNA control), 12.5 μl Maxima
SYBR Green qPCR Master Mix (Maxima SYBR Green
qPCR, Thermo Fisher Scientific), 0.3 μmol l−1 of each
forward and reverse primer, 10 nmol l−1/100 Nm ROX
Solution, nucleases-free water to a final volume of 25 μl.
The reaction was completed in AriaMx real-time PCR
(Agilent Technologies, USA) using a two-step protocol:
initial denaturation at 95 °C for 10 min, then 40 cycles of
denaturation at 95 °C for 15 s followed by annealing/ex-
tension at 60 °C for 60 s. A melting curve protocol was
run at the end of the PCR by heating at 95 °C for 30 s
followed by a 65 °C for 30 s and 95 °C for 30 s. The ex-
pression levels of target genes were normalized to the
housekeeping gene glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) while the expression of miRNAs
was normalized relative to U6 RNA as an internal
housekeeping reference gene. Relative gene expression
ratios (RQ) between treated and control groups were
calculated using the formula: RQ = 2−ΔΔCt [40]
Western blot
Anti-rabbit polyclonal antibodies against Oct-4 (Abcam,
ab18976)), Oct-4A (C30A3) mAb #2840), Sca-1 (Abcam,
ab95439), FSHr (Abcam, ab75200), and β-actin (Abcam,
ab8226), and anti-mouse monoclonal against Nanog
(Santa Cruz, Cat#sc8630), were used. Protein extraction
was performed using ice-cold 1X cell lysis buffer con-
taining 50 mmol Tris (SRL, Mumbai, India), 1 mmol
EDTA (Fischer Scientific, New York), 150 mmol NaCl
(Sigma-Aldrich), 1 mol sodium fluoride (Fischer Scien-
tific, Qualigens, Mumbai), 0.1% sodium dodecyl sulfate
(SDS; Fischer Scientific), 1% Triton X-100 (Sigma-Al-
drich), 2 mmol phenylmethylsulfonyl fluoride (Sigma-Al-
drich), and 4% protease inhibitor cocktail (Roche
Diagnostics, Manheim, Germany). Whole ovaries were
minced and homogenized by passing through 20G, 22G,
and 26G hypodermic needles.
The subsequent cell lysates were agitated on ice for 30
min followed by centrifugation at 21,000g for 30 min to
Table 1 Primer sequences and accession number of the studied genes
Gene Accession no. Primers sequences (5′ → 3′) Reference
SCP3 XM_032910940.1 F: TGTTGCAGCAGTGGGAACTGGAT [35]
R: CCATCTCTTGCTGCTGAGTTTCCA
Mvh XM_032898891.1 F: AGTGGAAGTGGTCGAGGTGGT [26]
R: TGCCGGTGGTGCATCATGTCC
Nobox NM_001192013.1 F: AGGGTGCTGAGAGGGTGGCAG [36]
R: GGCGATACTAGTGCCCCAGGAC
DAZL XM_032899416.1 F: GTGTGTCGAAGGGCTATGGAT [35]
R: ACAGGCAGCTGATATCCAGTG
Oct-4 XM_032889059.1 F: CCTGGGCGTTCTCTTTGGAAAGGTG [37]
R: GCCTGCACCAGGGTCTCCGA
Nanog NM_028016.3 F: CAGGAGTTTGAGGGTAGCTC [37]
R: CGGTTCATCATGGTACAGTC
Sca-1 NM_001310438.1 F: AGAGGAAGTTTTATCTGTGCAGCCC [35]
R: TCCACAATAACTGCTGCCTCCTGA
FSHr XM_021218040.1 F: TGGAGGCGGCAAACCTCTGAAC [38]
R: TCTGGCTTTGGCGAGCAGGTC
Oct-4A AH003838.2 F: CCATGTCCGCCCGCATACGA [37]
R: GGGCTTTCATGTCCTGGGACTCCT
GAPDH XM_032909104.1 F: ACCACAGTCCATGCCATCAC [37]
R: TCCACCACCCTGTTGCTGTA
Stra8 XM_006236282.3 F: CAGCCTCAAAGTGGCAGGTA Designed
R: GGGATTTCCGTCTTGCAGGT
BAX XM_032913059.1 F: CGGCGAATTGGAGATGAACTGG [39]
R: CTAGCAAAGTAGAAGAGGGCAACC
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assemble the supernatant. Protein concentration was
assessed by the Folin-Lowry method by means of a spec-
trophotometer (Beckman Coulter Inc, Indianapolis, Indi-
ana). The extracted protein was incubated in Laemmli
buffer for 10 min at 95 °C. Protein (50 mg loading) was
resolved using 10% SDS (sodium dodecyl sulfate) poly-
acrylamide gel electrophoresis and transferred onto poly-
vinylidene difluoride membrane (Amersham Biosciences,
Bucks, UK). The blot was blocked with 5% nonfat dry
milk (NFDM) in 1% TBS with Tween 20 overnight at
4 °C. The membrane was incubated with anti-OCT-4,
Oct-4A, Sca-1, Nanog, FSHr, and β-actin antibodies (1:
500; Ab3209, Millipore) at room temperature for 2 h
followed by incubation with goat anti-rabbit horseradish
peroxidase-conjugated secondary antibody (1:5000,
Millipore) for 2 h at room temperature.
Recognition was performed with Super Signal West
Femto substrate (Thermo Scientific, Waltham, Massa-
chusetts) on photographic films (Eastman Kodak Co,
Rochester, New York). The later blot was stripped via
stripping buffer (62.5 mmol Tris, 2% DS, 100 mmol β-
mercaptoethanol) for 10 min at 60 °C to detect house-
keeping protein. Actin was cast-off as housekeeping pro-
tein and detected using MAB1501 (Millipore) at a 1:
5000 dilutions with human embryonic stem cell extract
used as positive control. Afterward washing twice with
1X TBST, densitometric analysis of the immunoblots
was done to calculate the amounts of OCT-4, Oct-4A,
Sca-1, Nanog, FSHr, and β-actin against control sample
by total protein normalization using Image analysis soft-
ware on the Chemi Doc MP imaging system (Version 3)
made by Bio-Rad (Hercules, CA).
Histopathological analysis
Ovarian tissues were excised, fixed in 10% buffered
formol saline, and managed as 4-6-μm-thick paraffin
sections, followed by mounting on glass slides for
H&E and positively charged slides for immunohisto-
chemistry (IHC).
Half of the ovarian tissues were consumed for H&E
staining. Next to the fixation sections were dehydrated
with successive concentrations of ethanol and washed
twice in distilled water followed by staining with
hematoxylin and eosin (H&E). Lastly, the histological
sections were examined and analyzed under a micro-
scope (Leica DMR 3000; Leica Microsystem) by two
blinded experienced investigators [41].
Immunohistochemistry analysis
Paraffin sections were deparaffinized and hydrated. After
blocking the endogenous activity of peroxidase using
10% hydrogen peroxide, the sections were incubated
with primary rabbit polyclonal antibodies against PCNA
(proliferating cell nuclear antigen) (SAB4502103; 1:400
dilutions; Sigma-Aldrich, St Louis, Missouri, USA) and
rabbit polyclonal antibodies against FSHr (F3929; 1:100
dilutions; Sigma-Aldrich, St Louis, Missouri, USA).
Rabbit polyclonal antibodies against OCT4 (# PA5-
27438; 1:100-1:1000, Thermo Fisher Scientific). Also, we
used polyclonal rabbit antibodies against CD105
(SAB1306487; 1:10-1:50, Sigma-Aldrich) to investigate
homing of MSCs in ovarian tissues. Then, after washing
with phosphate buffer, the secondary antibody was ap-
plied (biotinylated goat anti-rabbit). The slides were in-
cubated with labeled avidin–biotin peroxidase, which
binds to the biotin on the secondary antibody. The site
of antibody binding was visualized after adding (diami-
nobenzedine) chromogen, which is converted into a
brown precipitate by peroxidase [42].
Morphometric study
The mean area % of PCNA, FSHr, nuclear OCT4, and
CD105 immuno-expression were quantified for five im-
ages from five non-overlapping fields from each rat of
each group using the Image-Pro Plus program version
6.0 (Media Cybernetics Inc., Bethesda, Maryland, USA).
Statistical analysis
Statistical analysis was performed using the statistical
software package SPSS for Windows (Version 16.0; SPSS
Inc., Chicago, IL, USA). Differences between groups
were evaluated using one-way analysis of variance
(ANOVA; F) and Kruskal Wallis test (χ2) to compare
more than two groups regarding parametric and non-
parametric data, respectively, followed by post hoc ana-
lysis to detect differences in pairs. For each test, all data
are expressed as the mean ± standard deviation (SEM),
and a P value < 0.05 was considered significant.
Results
Confirmation of BM-MSC isolation
BM-MSCs were recognized primarily after 2 weeks’ iso-
lation in culture via an inverted microscope as spindle-
shaped cells among rounded cells (Fig. 1a) and intraperi-
toneal injected BM-MSCs labeled with GFP were
observed using a fluorescent microscope (Fig. 1b). Cell
surface marker expression confirmed BM-MSC identity
via CD90 (92.5% positive expression), CD105 (98.7%
positive), and CD34 (0.7% positive) being consistent with
the ISCT MSC guidelines [43] (Fig. 1c). Confirmation of
the adipogenic, osteogenic, and chondrogenic differenti-
ation was also established (Fig. 1d–f). The localization
and homing of BM-MSCs were assessed in MSC-treated
groups (group IV and V) by assessing the immune-
expression of MSC surface marker (CD105) in ovarian
tissues (Fig. 1g–i).
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Gonadotrophin and BM-MSC supplementation promote
elevated serum estradiol E levels
Following on from ovarian chemo-ablation by combined
administration of busulfan daily for 4 days and 100 mg/
kg cyclophosphamide on the first 2 days, we sought to
determine whether gonadotrophin and BM-MSCs car-
ried with them a therapeutic effect. Following on from
chemo-ablation, and 1 month after therapeutic interven-
tion by gonadotrophin and MSCs, we measured serum
FSH and estradiol E concentrations using enzyme-linked
immunosorbent assay (ELISA) (Fig. 2). Serum FSH con-
centration was significantly (P < 0.05) higher in group II
(OA group) when compared with all other experimental
groups (Fig. 2a). No other groups displayed significant
elevation of serum FSH above control levels.
Estradiol E, a major female sex hormone, is pro-
duced by the growing ovarian follicles. Its level was
significantly (P < 0.05) decreased in the serum of
group II (OA group) when compared with all other
groups. Estradiol E levels in group V (OA + PMSG+
BM-MSCs group), treated with both gonadotrophin
and MSCs, were significantly higher (P < 0.05) than
all other groups (Fig. 2b).
A distinct molecular signature associates with
gonadotrophin and BM-MSC-supplemented ovaries
following on from chemo-ablation
We next explored expression of a range of transcripts
recognized as ovarian mediators (Fig. 3). Nanog, Sca-1,
and Oct-4a were upregulated in group II (OA group)
compared to control group (P < 0.05), while Scp3, Mvh,
Nobox, DAZL, Stra8, and Oct-4 were all downregulated
in group II (OA group) compared to control group (P <
0.05). Group III (OA + PMSG group) showed upregula-
tion of Mvh, DAZL, Oct-4, Nanog, Sca-1, FSHr, Oct-4a,
and Stra8 when compared with group II (OA group) (P
< 0.05). In contrast, Scp3 and Nobox were unchanged
between group III (OA + PMSG group) and group II
(OA group). Group IV (OA + BM-MSCs group) showed
Fig. 1 a An inverted microscope micrograph from primary culture
of mesenchymal stem cells (black arrow). b Fluorescent microscopic
image demonstrating fluorescence of MSCs labeled with GFP 2
weeks after implantation. c Flow cytometry analysis of surface
antigens of MSCs (blue is the isotype, green is the detected
antigen); CD34 0.7%, CD90 92.5%, and CD105 98.7%. d Osteogenesis
differentiation stained with Alizarin red stain and its control. e
Adipogenesis differentiation stained with Oil Red O stain and its
control. f Chondrogenesis differentiation stained with Alcian blue
stain and its control. g CD105 immuno-expression in group VI. h
CD105 immuno-expression in group V. i Histogram representing the
mean area percentage of CD105 immunoreaction in treated groups
(group IV and V). The significant differences against chemo-ablated
group indicated by a “*” for p < 0.05 and a “**” for p < 0.01. Data are
shown as mean ± S.E.M, n = 7
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upregulation in Mvh, DAZL, Oct-4, and FSHr expres-
sion (P < 0.05) and no change in Scp3, Nobox, Stra 8,
Nanog, Sca-1, and Oct-4a when compared with group II
(OA group). Group V (OA + PMSG+ BM-MSCs group)
displayed significant upregulation of all measured genes
when compared with group II (OA group) and to a
greater extent than seen in other groups (P < 0.05).
In contrast to the general trend noted above BAX
was upregulated in group II (OA group) when com-
pared to the control group (P < 0.05). Further, both
groups IV (OA + BM-MSCs group) and V (OA +
PMSG+ BM-MSCs group) displayed downregulation
of BAX expression when compared to either group II
or group III (P < 0.05).
miR-143 and miR-376a have distinct roles in primordial
follicle pool formation and maintenance
miR-143 is described as playing a role in inhibition of
primordial follicle formation by suppressing pregranu-
losa cell proliferation and downregulation of cell cycle-
related genes [44] Significant upregulation of miR-143
expression was noted for group II (OA group) vs. group
I (control group). Consistent with above, both groups IV
(OA + BM-MSCs group) and V (OA + PMSG+ BM-
MSCs group) showed downregulation of miR-143 when
compared with group II, and group I for group V (OA +
PMSG+ BM-MSCs group) (P < 0.05) (Fig. 4).
miR-376a is described as a stimulator of ovarian sur-
face epithelial cell proliferation. Expression of ovarian
miR-376a was downregulated in group II (OA group)
when compared with the control group (P < 0.05) while
the control group and group III (OA + PMSG+ group)
displayed comparable expression levels. Groups IV (OA
+ BM-MSCs group) and group V (OA + PMSG+ BM-
MSCs group) both displayed a significant upregulation
of miR-376a when compared with either groups I or II
(P < 0.05) (Fig. 4).
Western blotting of selected key proteins as a
confirmation of transcript expression changes
Western blotting and quantitative analysis confirmed
that Nanog, Sca-1, Oct-4a, and FSHr proteins were up-
regulated in group II (OA group) vs. the control group
(P < 0.05), while Oct-4 protein was downregulated in
group II vs. group I (P < 0.05). Group IV (OA + BM-
MSCs group) showed upregulation of Oct-4 and FSHr
protein (P < 0.05) and no change in Nanog, Sca-1, and
Oct-4a when compared with group II (OA group).
Group II (OA + PMSG group) and group V (OA +
PMSG+ BM-MSCs group) showed higher expression of
all five proteins when compared with group II (Fig. 5).
Histological findings underlying postnatal oogenesis of
chemo-ablated ovaries treated with gonadotrophin and
BM-MSCs
No histological differences were observed upon examin-
ation of ovarian sections from the control subgroups.
Therefore, the results of subgroup Ia were used to repre-
sent the control group.
H&E results
Group I (control group) revealed a normal ovarian struc-
ture. The surface of the ovaries was covered by germinal
epithelium consisting of a single layer of cuboidal cells.
Follicles in different stages of development were ob-
served in the cortex. Primordial follicles were found be-
neath the germinal epithelium and consisted of primary
oocytes surrounded by a single layer of squamous epi-
thelium. The oocytes of the unilaminar primary follicles
were surrounded by a single layer of cuboidal granulosa
cells while those of the multilaminar primary follicles
were surrounded by multiple layers of granulosa cells.
Several atretic follicles were seen in addition to mature
Graafian follicles (Fig. 6a). Ovaries from group II (OA
group) demonstrated prominent histological alterations
in the form of flat germinal epithelium, a marked
Fig. 2 Serum FSH (a) and estradiol E (b) concentrations after rat’s scarification. The significant differences against chemo-ablated group indicated
by a “*” for p < 0.05 and a “**” for p < 0.01. Data are shown as mean ± S.E.M, n = 7
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Fig. 3 Quantitative analysis for relative expression of Scp3, Mvh, Nobox, Dazl, Oct-4, Nanog, Sca-1, FSHr, Stra8, Oct-4-A, and BAX. The significant
differences against chemo-ablated group indicated by a “*” for p < 0.05 and a “**” for p < 0.01. Data are shown as mean ± S.E.M, n = 7
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reduction in primordial follicles, and severe atresia of
the existing follicles. Secondary follicles had shrunken
oocytes and wide separation of their surrounding granu-
losa cells (Fig. 6b). Treatment with gonadotropin alone
in group III (OA + PMSG group) induced areas of
prominent stratification of the germinal epithelium with-
out primordial follicles, and follicles that appeared
atretic (Fig. 6c). Group IV (OA + BM-MSCs group)
ovaries displayed flat germinal epithelium with primor-
dial and unilaminar follicles in the cortex (Fig. 6d). In
group V (OA + PMSG+ BM-MSCs group), recipient of
combined gonadotropin and MSC treatment, cuboidal
germinal epithelium, numerous primordial, unilaminar,
and mature Graafian follicles were observed (Fig. 6e).
Immunohistochemistry results
PCNA immunohistochemistry Group I (control group)
revealed no evidence of nuclear PCNA in either the sur-
face epithelial or stromal cells while positive labelling
was observed in the follicular cells and the oocytes of
the primordial follicles (Fig. 7a). Group II (OA group)
displayed an absence of labelling in the surface epithelial,
follicular, and stromal cells (Fig. 7b). Group III (OA +
PMSG group) displayed strong immunolabelling in the
stratified surface epithelial cells but none in either the
follicular or stromal cells (Fig. 7c). Group IV (OA + BM-
MSCs group) revealed an element of positive labelling in
the surface epithelial and stromal cells while a positive
reaction was observed in the follicular cells (Fig. 7d).
Finally, group V (OA + PMSG+ BM-MSCs group) dis-
played positive immunolabelling in the surface epithelial
and follicular cells as well as the primary oocytes of the
primordial follicles but not in the stromal cells (Fig. 7e).
The histogram representing the area percentage of
PCNA in all groups (Fig. 9f).
FSHr immunohistochemistry Groups I (control group)
and group II (OA group) displayed low levels of FSHr-
labelling in the surface epithelial cells (Fig. 8a,b). Groups
III (OA + PMSG group) and group IV (OA + BM-MSCs
group) revealed a moderate reaction in stratified surface
epithelial cells (Fig. 8c,d). While in the combined treat-
ment recipient group V (OA + PMSG+ BM-MSCs group),
a strong labelling was detected in many of the surface epi-
thelial cells (Fig. 8e). The histogram representing the area
percentage of FSHr in all groups (Fig. 9f).
OCT4-A immunohistochemistry Groups I (control
group) displayed minimal nuclear immuno-expression of
OCT4-A in the surface epithelial cells indicating low
level of VSELs in ovarian surface epithelial cells (Fig. 9a).
While in group II (OA group), the VSELs resist chemo-
therapy giving mild nuclear immune-expression of
OCT4-A in ovarian surface epithelial cells (Fig. 9b). In
group III (OA + PMSG+ group), there were moderate
nuclear OCT4-A immuno-expression compared to con-
trol group indicating increased percentage of VSELs in
ovarian surface epithelial cells (Fig. 9c). While in BM-
MSC-treated group (group IV), the nuclear OCT4-A
immuno-expression was minimal indicating no change
in VSEL percentage within ovarian surface epithelial
cells compared to the chemo-ablated group (Fig. 9d).
The nuclear OCT4-A immuno-expression in group V
(combined therapy of BM-MSCs and gonadotropin)
were severely increased compared to chemo-ablated
group indicating increased number of VSELs in ovarian
surface epithelial cells (Fig. 9e). The histogram repre-
senting the area percentage of OCT4-A in all group (Fig.
9f).
Discussion
Until recently, fertility preservation protocols in women
have been constrained by the theory that the oocyte re-
serve, endowed at birth, was fixed and indispensable.
This theory was challenged by a report detailing the
identification of mitotically active germ cells in postnatal
mice ovaries capable of supporting de novo oogenesis
Fig. 4 Quantitative analysis for relative expression of miR-143 and miR-376a. The significant differences against chemo-ablated group indicated by
a “*” for p < 0.05 and a “**” for p < 0.01. Data are shown as mean ± S.E.M, n = 7
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and folliculogenesis throughout adult life [7, 45]. A large
body of evidence has now verified postnatal oogenesis in
mammals [46, 47], and the characteristic features and
functional properties of the germ cells responsible for
continued oocyte formation [48]. These cells, termed
female germline or oogonial stem cells, have been
detected and separated for studying, adult ovarian tissue
of mice [47, 49], rats [50], cows [51], pigs [52], nonhu-
man primates [53], and women [18, 49, 54].
Cyclophosphamide and busulfan were used to induce
ovarian chemo-ablation in rats. As ovaries express the
enzymes necessary estrogen for the synthesis of [55] and
that the majority of E2 is formed within the granulosa
cells during the development of follicles under the effect
of FSH and LH [56], these were utilized to establish
chemo-ablation and recovery. Ovarian chemo-ablation
was confirmed in group II by decreased serum estradiol
E2, increased FSH, and histopathological examination
that indicated decreased numbers of primordial follicles
and severe atresia of the existing follicles, and flat germi-
nal epithelium with little or no PCNA presence across
surface epithelia, follicular, or stromal cells. Further,
Fig. 5 Western blot for Oct-4, Oct-4A, Sca-1, Nanog, FSHr, and GAPDH. Quantified using image analysis software on the Chemi Doc MP
imaging system
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epithelial surface cells displayed FSHr expression indi-
cating the potential presence of limited amounts of
VSELS [32] These observations are consistent with re-
ports detailing the depletion of primordial follicles and
follicular atresia with extreme diminishing in ovarian
function and eventual failure, after chemotherapy in rats
[57]. The mechanism underpinning the primordial folli-
cles loss in response to chemotherapy is not well under-
stood. It might be attributed to an accelerated process of
natural ovarian aging due to a direct cytotoxic influence
on oocytes and a portion of primordial follicles, imped-
ing folliculogenesis [58]. An alternative explanation to
primordial follicle depletion after chemotherapy might
be attributed to damaged cortical blood vessels and neo-
vascularization. As the blood supply to the ovary is an
end-artery system, therefore, congestion of blood vessels
and marked thickening of the wall of blood vessels with
obliteration of their lumina will result in local ischemia,
destroying regions of the normal ovarian cortex with loss
of primordial follicles [7].
In agreement with previous observations, we report
the existence of two populations of potential stem cells
in the adult mouse ovary [23, 59]. They are VSELs dem-
onstrated by expression of nuclear OCT-4, SCA, and
Nanog, and progenitors termed OGSCs characterized by
cytoplasmic OCT-4. Control ovaries had reduced Oct-
Fig. 6 Representative photomicrographs of hematoxylin and eosin-stained sections of the different experimental groups. a Group I (control
group) showed the germinal epithelium (thin arrow), primordial follicles (arrowheads), unilaminar (UL), and multilaminar (ML) primary follicles.
Several atretic follicles (A) and a mature Graafian follicle (GF) were also observed. b Group II (OA group) showed flat ovarian surface (germinal)
epithelial cells (thin arrow). No primordial follicles were observed. Secondary follicles (curved arrows) showed shrunken oocytes and wide
separation of the surrounding granulosa cells. c Group III (OA + PMSG group) showed an area of prominent germinal epithelium stratification. No
primordial follicles were seen, and the follicles appear atretic (A). d Group IV (OA + BM-MSCs group) showed flat germinal epithelium (thin arrow),
numerous primordial (arrowheads), and unilaminar (UL) follicles. e Group V (OA + PMSG+ BM-MSCs group) showed cuboidal germinal epithelium
(thin arrow), numerous primordial (arrow heads), unilaminar (UL), and a mature Graafian follicle (GF). f Histogram representing the mean number
of ovarian follicle in all experimental groups. The significant differences against chemo-ablated group indicated by a “*” for p < 0.05 and a “**” for
p < 0.01. Data are shown as mean ± S.E.M, n = 7
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4A expression compared to total Oct-4, implying less
VSEL presence and not OGSCs. On the other hand,
chemo-ablated ovaries displayed less Oct-4 than Oct-4A
transcript while the Oct-4A to Oct-4 ratio was higher
than in controls, implying a predominance of VSELs.
This is consistent with previous studies which re-
vealed that chemotherapy destroyed, as expected, the
ovarian follicular reserve and the potential OGSCs
[23, 60]. VSELs may have survived due to their quies-
cence and silenced mitogenic growth response signal-
ing pathways [32].
MicroRNAs (miRNAs) are linked to steroidogenesis,
ovarian gonadal development, apoptosis, and mammalian
ovulation [61–63]. Specific miRNAs in follicular develop-
ment, mir-143, and miR-376a, are major negative and
positive regulators of the formation and maintenance of
the primordial follicle pool [64]. miR-143 is reported to in-
hibit the formation of mouse primordial follicles by
downregulation of expression of cell cycle genes and sup-
pressing the proliferation of pregranulosa cells [44]. This
is potentially attributable to its ability to mediate the pro-
liferative signaling pathway of FSH by FSHR targeting and
the resultant inhibition of estradiol production and granu-
losa cell proliferation. Decreased expression of miR-143 in
the OA + PMSC group is in broad agreement with earlier
reports detailing the inhibition of miR-143 by FSH and
TGF-β [44]. miR-376a stimulates ovarian proliferation as
a positive regulator for formation and maintenance of the
primordial follicle pool [64]. The expression of ovarian
miR-376a was downregulated in the OA group when
compared with the control group. The overexpression of
ovarian miR-376a in the OA + PMSG + MSCs group mir-
rors high proliferation rates of primordial follicles as well
as the reduction of oocyte apoptosis. Concomitant with
these results, Zhang et al. [44] reported that the miR-376a
controls primordial follicle assembly via controlling PCNA
Fig. 7 Representative photomicrographs of FSHr immunoreaction sections of the different experimental groups. a Group I (control group)
showed a very mild positive nuclear reaction in a few of the surface epithelial cells. b Group II (OA group) showed limited FSHr nuclear
expression in select surface epithelial cells. c, d Group III and group IV (OA + PMSG group and OA + BM-MSCs group) revealed a moderate FSHr
expression in stratified surface epithelial cells. e Group V (OA + PMSG+ BM-MSCs group) resulted in a strong FSHr expression in the majority of
surface epithelial cells. f Histogram representing the mean area percentage of FSHr immunoreaction in all experimental groups. The significant
differences against the chemo-ablated group indicated by a “*” for p < 0.05 and a “**” for p < 0.01. Data are shown as mean ± S.E.M, n = 7
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expression, a gene formerly reported to control primordial
follicle assembly via controlling oocyte apoptosis in the
ovarian mouse.
We demonstrated increased serum FSH and estradiol
in group III (OA + PMSG group) in comparison to
chemo-ablated group, as the VSELs were stimulated by
PMSG treatment (indicated by increased Oct-4A,
Nanog, and FSHr) expression, underwent proliferation
(indicated by increased PCNA staining and Oct-4A ex-
pression), and further differentiation into germ cells (in-
dicated by increased expression of total Oct-4, MVH,
and DAZl) resulting in initiation of meiosis (indicated by
increased expression of Stra-8, which is specifically
expressed gene in mammalian germ cells. It is necessary
for the initiation of meiosis and is expressed by ovarian
germ cells just before the initiation of meiosis [10].
However, germ cells did not enter meiosis, with SCP3
neither expressed nor identified at the protein level in
any of the experimentations. These results are in agree-
ment with Bhartiya et al. [65] who recently reviewed the
possible role of stem cells, FSH, and ovarian biology
[65]. FSH increased proliferation of mouse OSE through
oncogenic pathways activation in surface epithelial cells
[65]. These oncogenic pathways include AKT, Birc5,
Cdk2, Cdk4, and Cdkn2a [66]. Similarly, ovarian stem
cells of sheep express FSH receptors and experience
clonal expansion and proliferation in response to FSH
through the novel FSHr transcript R3 [67]. Likewise,
Fig. 8 Representative photomicrographs of PCNA immune-stained sections of the different experimental groups. a Group I (control group)
showed a negative nuclear reaction in the surface epithelial cells (thin arrow) and stromal (S) cells and a positive reaction in the primary oocytes
of primordial follicles (arrowheads) and the follicular cells (F). b Group II (OA group) showed negative reaction in the surface epithelial cells (thin
arrow), follicular (F), and stromal (S) cells. c Group III (OA + PMSG group) showing an intense reaction in the stratified surface epithelial cells (thin
arrows) with a negative reaction in the follicular (F) and stromal (S) cells. d Group IV (OA + BM-MSCs group) showed a negative reaction in the
surface epithelial cells (thin arrow) and stromal(S) cells and a positive reaction in the follicular (F) cells. e Group V (OA + PMSG+ BM-MSCs group)
showed a positive reaction in the surface epithelial cells (thin arrow), primary oocytes of the primordial follicles (arrow heads), and follicular (F)
cells with a negative reaction in the stromal (S) cells. f Histogram representing the mean area percentage of PCNA immunoreaction in all
experimental groups. The significant differences against chemo-ablated group indicated by a “*” for p < 0.05 and a “**” for p < 0.01. Data are
shown as mean ± S.E.M, n = 7
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Sriraman et al. [68] reported that FSH treatment in-
duced mouse ovarian stem cell proliferation and clusters
formation and further differentiation into germ cells.
These findings were confirmed histologically by promin-
ent stratification of the germinal epithelium; however,
no primordial follicles were observed, and the follicles
remained atretic in appearance. Further, increased FSHr
expression in group III (OA + PMSG group) compared
to group II with accompanied PCNA expression was ob-
served in the stratified surface epithelial cells and not
the stromal and follicular cells. Nevertheless, the germ
cells in chemo-ablated ovaries faced meiotic block,
which is not overcome by FSH alone, and hence they
proposed the requirement for additional factors. It is
expected that in women with primary ovarian insuffi-
ciency and high levels of FSH, stem cells may experience
proliferation and initial differentiation. Nevertheless,
primordial follicle assembly and haploid oocyte forma-
tion may necessitate additional factors, that are not
available in the compromised somatic niche (as a result
of chemotherapy).
The apparent inability of VSELs to undergo differenti-
ation may be a consequence of the compromised
somatic niche as a result of treatment [4]. To attempt to
overcome this, we provided an additional supplemental
transplantation of MSCs with the aim of aiding niche
restoration to support further differentiation of VSELs
into gametes. Several studies of transplanted stem cells
Fig. 9 Representative photomicrograph of OCT4-A immunoreaction sections of different experimental groups. a Group I (control group)
displayed minimal nuclear immuno-expression of OCT4-A in the surface epithelial cells. b Group II (chemo-ablated, OA group) showed mild
nuclear OCT4-A immuno-expression in the surface epithelial cells. c Group III (OA + PMSG group) showed moderate nuclear OCT4A immuno-
expression in the surface epithelial cells. d Group IV (OA + BM-MSCs group) showed minimal OCT4-A immuno-expression. e Group V (OA +
PMSG+ BM-MSCs group) showed extensive immuno-expression of nuclear OCT4-A in the surface epithelial cells. f Histogram representing the
mean area percentage of OCT4-A immunoreaction in all experimental groups. The significant differences against the chemo-ablated group
indicated by a “*” for p < 0.05 and a “**” for p < 0.01. Data are shown as mean ± S.E.M, n = 7
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into a particular microenvironment have shown their
stimulation by the niche. Micro-environmental stimuli,
in turn, can trigger the paracrine secretion of growth
factors which energize the regeneration of the surround-
ing tissue and potentially drive differentiation of both
themselves and resident tissue-specific cell [69].
We have demonstrated higher FSHr mRNA and pro-
tein expression in group IV versus group II, suggesting
that MSC administration promoted an increase in the
cells number, as these, alongside VSELs, express FSHr
[68]. It remains unclear if the MSCs differentiated into
granulosa cells or the secreted trophic factors from
MSCs enabled a revitalization of the damaged endogen-
ous granulosa cells. However, no evidence was apparent
to suggest that MSCs differentiated into oocytes in re-
cipient rats as evidenced by the lack of the premeiotic
(Stra8) and the meiotic (SCP3) markers, in agreement
with the demonstration that MSCs did not create de
novo germ cells (eggs) within implanted (donor) tissues
[46]. Notwithstanding, the number of primordial and
growing follicles after MSC treatment was not equivalent
to the greater numbers present in the age-matched con-
trol group. Histological observation confirmed a flat ger-
minal epithelium with primordial and unilaminar
follicles in the cortex. FSHr expression was moderate
while PCNA expression was detected in only a few sur-
face epithelial and stromal cells with greater levels ob-
served in the follicular cells. These observations
demonstrated that MSC administration did not com-
pletely restore ovarian function to normal levels instead
having a role limited to rescue of follicles experiencing
early atresia or alternatively protecting quiescent primor-
dial follicles from the opposing effects of chemotherapy
in microenvironment of ovaries [70].
Folliculogenesis necessitates a cautiously orchestrated
crosstalk between germ cells and surrounding somatic
cells [71]. We found that combined injection of MSCs
and PMSG caused a significant increase in the number
of ovarian follicles and corpora lutea that was accom-
panied by restoration of E2 and FSH expression. This is
in broad agreement with previous studies which found
that the MSC-treated group upregulated proteins in-
volved in epigenetic regulation, transcription, protein
modification, and cell signaling [10, 72]. MSCs repaired
the damage of ovarian tissues through the growth of
granulosa cells that are stimulated by these pathways.
In addition to promoting repair of damaged ovarian
cells, a combined injection of MSCs and PMSG dramat-
ically reduced apoptosis of granulosa cells in the devel-
oping follicle. This reduction in apoptotic rate was
accompanied by decreased BAX expression when com-
pared to the chemo-ablated group.
Previous reports have suggested that MSCs inhibit
apoptosis by the secretion of stanniocalcin-1 and other
paracrine factors [73]. Therefore, we hypothesize that
the combined theory applied above has reactivated host
oogenesis, which is otherwise impaired following chemo-
therapy. The supplementation of MSCs and PMSG
following on from chemo-ablation resulted in increased
mRNA of germ cell-specific markers (OCT4, Dazl,
MVH) suggesting increased differentiation of VSELs to
germ cells. Moreover, meiosis was sustained by the
expression of premeiotic (Stra8) besides meiotic (Scp3)
markers. Furthermore, increased expression of the
oocyte-specific marker (Nobox), which is expressed
plentifully in primordial plus primary follicular oocytes
[74], and the antiapoptotic factor in granulosa cells and
folliculogenesis marker (FSHr) were noted [4]. These
data suggest that combined injection of MSCs and
PMSG amplifies the ovarian stem cell differentiation
process as well as meiosis creating new oocytes, which
are subsequently collect by granulosa cells to collect as
primordial follicles, supporting the earlier proposal of
postnatal oogenesis [75]. Noticeably, primordial follicles
at birth are normally arrested in the diplotene stage of
prophase 1 of meiosis while Scp3 expression constrained
to former stages, i.e., zygotene and pachytene stages [7,
36]. Therefore, expression of Stra8 and Scp3 in the adult
ovaries reflected evidence in supporting postnatal
oogenesis.
Proliferating cell nuclear antigen (PCNA), an auxiliary
protein of DNA polymerase enzymes, is used as a
standard marker in proliferative cells [76]. Here, after
chemotherapy, the vast majority of surface epithelial
cells lacked PCNA expression. Following on from
MSC and PMSG therapy, expression of PCNA was
restored to surface epithelial cells when compared to
the chemo-ablated group and the group treated with
PMSG alone. Thus, MSCs possibly migrated from the
bone marrow toward the ovary, to become a source of
germline stem cells capable of regenerating the popu-
lation of primordial follicles. Besides, they improve
the microenvironment needed for oogenesis. This was
certainly reflected in a significant increase in the
number of primordial follicles. It has been shown that
PCNA is also tangled in DNA repair. Thus, DNA
polymerase delta might be activated to repair possible
damage to the genetic material in the oocytes selected
to grow [77]. Increased PCNA expression in the oocyte
nucleus could also reflect the increased expression of
growth factors in the oocyte, as PCNA expression can be
stimulated by various growth factors even in quiescent
cells.
Taken together, the results of this study suggest the
presence of potential VSELs in rat ovaries that they sur-
vive chemotherapy, are modulated by FSH and enhanced
by a combination of FSH and MSC, and retain the ability
to undergo oocyte-specific differentiation.
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Conclusion
MSC co-administration improved the local microenvir-
onment of the ovary and integrated with PMSG to
promote follicular development into mature oocytes ap-
parently by granulosa cell function. The accompanying
evidence of postnatal oogenesis provides relevance to
women who experience premature ovarian failure be-
cause of oncotherapy.
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